The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category MidCapGrowth
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
SHPAX | 19.36 | 0.10 | +0.52% |
Saratoga Health & Biotechnology A | |||
SHSCX | 45.89 | 0.22 | +0.48% |
BlackRock Health Sciences Opps Inv C | |||
TLARX | 12.11 | 0.05 | +0.41% |
Transamerica Large Core ESG R | |||
NSGCX | 19.99 | 0.06 | +0.30% |
Columbia Select Large Cap Equity C | |||
AILLX | 28.11 | 0.07 | +0.25% |
Aristotle Core Equity I-2 |
A.I.dvisor indicates that over the last year, PJGQX has been closely correlated with PEMGX. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if PJGQX jumps, then PEMGX could also see price increases.
Ticker / NAME | Correlation To PJGQX | 1D Price Change % | ||
---|---|---|---|---|
PJGQX | 100% | +0.87% | ||
PEMGX - PJGQX | 89% Closely correlated | +0.70% | ||
PMBJX - PJGQX | 89% Closely correlated | +0.73% | ||
PMBMX - PJGQX | 89% Closely correlated | +0.70% | ||
PMBCX - PJGQX | 89% Closely correlated | +0.69% | ||
PMBPX - PJGQX | 89% Closely correlated | +0.70% | ||
More |